Citizens National Bank Trust Department’s Thermo Fisher Scientific TMO Stock Holding History

Citizens National Bank Trust Department’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.79M	Buy	5,567 +312	+6%	+$150K	0.41%	61
2026 Q1	$2.58M	Sell	5,255 -148	-3%	-$80.3K	0.43%	59
2025 Q4	$3.13M	Buy	5,403 +2	+0%	+$1.13K	0.54%	50
2025 Q3	$2.62M	Buy	5,401 +304	+6%	+$142K	0.47%	57
2025 Q2	$2.07M	Buy	5,097 +214	+4%	+$89.5K	0.41%	69
2025 Q1	$2.43M	Buy	4,883 +188	+4%	+$102K	0.52%	57
2024 Q4	$2.44M	Buy	4,695 +50	+1%	+$27.5K	0.52%	53
2024 Q3	$2.87M	Sell	4,645 -210	-4%	-$124K	0.6%	48
2024 Q2	$2.68M	Sell	4,855 -70	-1%	-$40.1K	0.6%	47
2024 Q1	$2.86M	Buy	4,925 +4	+0.1%	+$2.25K	0.66%	44
2023 Q4	$2.61M	Buy	4,921 +53	+1%	+$25.7K	0.66%	47
2023 Q3	$2.46M	Buy	4,868 +41	+0.8%	+$21.8K	0.68%	45
2023 Q2	$2.52M	Buy	4,827 +145	+3%	+$78.2K	0.67%	45
2023 Q1	$2.7M	Sell	4,682 -5	-0.1%	-$2.82K	0.75%	42
2022 Q4	$2.58M	Sell	4,687 -45	-1%	-$23.8K	0.73%	43
2022 Q3	$2.4M	Buy	4,732 +180	+4%	+$101K	0.74%	43
2022 Q2	$2.47M	Buy	4,552 +1,120	+33%	+$616K	0.71%	49
2022 Q1	$1.9M	Sell	3,432 -45	-1%	-$25.9K	0.76%	44
2021 Q4	$2.32M	Sell	3,477 -1,055	-23%	-$659K	0.88%	35
2021 Q3	$2.59M	Buy	4,532 +47	+1%	+$25.8K	0.74%	44
2021 Q2	$2.26M	Buy	4,485 +318	+8%	+$150K	0.65%	55
2021 Q1	$1.9M	Buy	4,167 +337	+9%	+$161K	0.58%	63
2020 Q4	$1.78M	Buy	3,830 +1,935	+102%	+$907K	0.58%	60
2020 Q3	$837K	Buy	1,895 +195	+11%	+$80.6K	0.33%	75
2020 Q2	$616K	Hold	1,700	–	–	0.26%	78
2020 Q1	$482K	Buy	+1,700	New	+$536K	0.26%	74

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citizens National Bank Trust Department's TMO Position: Q2 2026 in Review

Citizens National Bank Trust Department increased its Thermo Fisher Scientific (TMO) stake by 5.9% in Q2 2026, buying an estimated $150K and bringing the position to 5,567 shares worth $2.79M. The position accounts for 0.41% of the portfolio, ranked #61.

Citizens National Bank Trust Department first reported a position in TMO in Q1 2020 and has held it in 26 quarters since. The position peaked at $3.13M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Citizens National Bank Trust Department held 5,567 shares of Thermo Fisher Scientific worth $2.79M as of Q2 2026.
Citizens National Bank Trust Department bought 312 Thermo Fisher Scientific shares in Q2 2026, an estimated $150K.
Thermo Fisher Scientific made up 0.41% of Citizens National Bank Trust Department's portfolio in Q2 2026, its #61 holding.
Citizens National Bank Trust Department first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 26 quarters since.
Citizens National Bank Trust Department's Thermo Fisher Scientific position peaked at $3.13M in Q4 2025.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Citizens National Bank Trust Department's 13F filing for Q2 2026, filed 22 Jul 2026.